Subject
International Clinical Psychopharmacology is a bimonthly peer-reviewed medical journal published by Wolters Kluwer Health. It covers neuropsychopharmacology and clinical psychiatry. It was established in 1986. The editor-in-chief is Alessandro Serretti (University of Bologna). Source: Wikipedia (en)
Editions published in International Clinical Psychopharmacology 200
Too many entities requested (2101). Only 200 are displayed.
-
Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trials
-
Utility of functioning in predicting costs of care for patients with mood and anxiety disorders: a prospective cohort study
-
Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study
-
Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysis
-
Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs
-
Treatment of cocaine craving with as-needed nalmefene, a partial κ opioid receptor agonist: first clinical experience
-
Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis
-
Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial.
-
Caffeine-induced psychiatric manifestations: a review
-
Efficacy of treatments for anxiety disorders: a meta-analysis
-
Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia
-
The beneficial effect of escitalopram on obsessive-compulsive-related musical hallucinations in elderly patients with hearing impairment: a case series
-
The advantage of using 3-week data to predict response to aripiprazole at week 6 in first-episode psychosis.
-
Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions
-
Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalization
-
Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia
-
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
-
Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study
-
Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials
-
Pharmacotherapy in the treatment of patients with borderline personality disorder: results of a survey among psychiatrists in private practices
-
The use of psychiatric drugs and worsening body mass index among inpatients with schizophrenia
-
Venlafaxine extended-release treatment of hoarding disorder
-
Pharmacokinetics of olanzapine long-acting injection: the clinical perspective
-
Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
-
Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: a 6-year, multinational, single-arm, open-label study
-
Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
-
The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind, placebo-controlled study
-
Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trials
-
Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term data
-
The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: a review.
-
Evaluation of the effect of duloxetine treatment on functioning as measured by the Sheehan disability scale: pooled analysis of data from six randomized, double-blind, placebo-controlled clinical studies
-
No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial
Subject - wd:Q15751307